Citation

Kouchaki E, Namdari M, Khajeali N, Etesam F, Asgarian FS. Soc. Work Public Health 2020; 35(8): 655-663.

Copyright

(Copyright © 2020, Informa - Taylor and Francis Group)

DOI

10.1080/19371918.2020.1810839

PMID

32865151

Abstract

The aim of this study is to estimate the worldwide prevalence of suicidal ideation in multiple sclerosis patients. Two researchers selected words such as "epidemiology" or "prevalence" or "incidence" and "suicidal ideation in multiple sclerosis" and searched them as relevant keywords in international databases such as PubMed, Web of Science CINAHL, Embase, Psyc INFO, and Scopus. A point prevalence with 95% confidence interval was estimated. The variances of each study were calculated using the binomial distribution formula. Heterogeneity among the studies was tested by a Q-Cochran test with a significance level less than 0.1. Index of changes attributed to heterogeneity (I2) was assessed. From among the 170 total articles found from 2011 to February 2019, we pooled and analyzed the data of eight final eligible studies, based on the inclusion criteria. The prevalence of suicidal ideation in multiple sclerosis patients was estimated as 13% (CI 95% = 0.09-0.17). A subgroup analysis was conducted based on the type of countries; it revealed that prevalence is higher in developed countries (15%; CI 95% = 0.1-0.2). Pooled worldwide prevalence of suicidal ideation in the MS population was calculated at 13% by random effect. It is recommended that training, counseling, and psychological support be used to help these patients.

Language: en

Keywords

Humans; Meta-analysis; multiple sclerosis; Multiple Sclerosis; Patients; prevalence; Prevalence; suicidal ideation; Suicidal Ideation